Transthoracic closure of atrial septal defect and ventricular septal defect without cardiopulmonary bypass
| Autor: | Tang J, Qun Wang, Li Wan, Qi-rong Xu, Wenjun Wang, Qi-cai Wu, Yuanping Cao, Hua Xu, Liu-gen Zeng, Jichun Liu, Yu Bt |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
Adult
Heart Septal Defects Ventricular Male Aortic valve medicine.medical_specialty Adolescent Heart disease Heart Septal Defects Atrial law.invention Young Adult law Internal medicine Occlusion Genetics Cardiopulmonary bypass Humans Minimally Invasive Surgical Procedures Medicine Cardiac Surgical Procedures Child Molecular Biology Coronary sinus Aged Retrospective Studies Atrioventricular valve Heart septal defect Cardiopulmonary Bypass business.industry Infant General Medicine Middle Aged medicine.disease Treatment Outcome medicine.anatomical_structure Child Preschool Cardiology Female business Atrioventricular block |
| Zdroj: | Genetics and Molecular Research. 14:3760-3766 |
| ISSN: | 1676-5680 |
| DOI: | 10.4238/2015.april.22.4 |
| Popis: | The minimally invasive surgical transthoracic occlusion of an atrial septal defect (ASD) or a ventricular septal defect (VSD) is an increasingly widespread alternative treatment for congenital heart disease. The aim of this study is to summarize our clinical experience with minimally invasive surgical transthoracic occlusion of ASD and VSD without cardiopulmonary bypass (CPB). Between April 2011 and October 2012, 27 patients with ASD and 95 patients with VSD (78 men and 44 women) were considered for minimally invasive surgical transthoracic occlusion without CPB. A small infrasternal incision (2.0-4.0 cm) was made under general anesthesia, under transesophageal echocardiography (TEE) guidance; the ASD and VSD were closed by using an appropriate occluder; and TEE was performed simultaneously to demonstrate the position of the device, any residual shunting, or encroachment on the atrioventricular valve, coronary sinus, or aortic valve. Successful transthoracic occlusion was performed in all 122 patients without complications. No complications such as third-degree atrioventricular block and residual shunting occurred after the procedures. The ventilation time was 2.2 ± 1.2 h, and the average length of hospital stay was 4.7 ± 1.7 days. All patients received aspirin at 3 mg·kg(-1)·day(-1) (maximum 100 mg/day) 24 h after the procedure. Minimally invasive surgical transthoracic occlusion without CPB is a new treatment that has many advantages such as causing little trauma, promoting quick recovery, having less complications, and avoiding radiation damage. However, the appropriate selection of patients is still key to improving the success rate of the operation. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|